Executive Director Finance, GPS Strategy & Capital at Bristol-Myers Squibb

Princeton, New Jersey, United States

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, ManufacturingIndustries

Requirements

  • Master’s degree in Finance, Business Administration, Accounting, or a related field; CPA or CMA designation preferred
  • Minimum of 15 years’ progressive experience in finance roles
  • Demonstrated experience in capital planning, financial analysis, and business development within a global context
  • Proven track record of supporting strategic product and network decisions, including plant expansions, consolidations, and new product introductions
  • Strong understanding of manufacturing cost structures, supply chain economics, and asset optimization strategies
  • Exceptional leadership skills, with the ability to influence cross-functional teams and drive alignment on financial priorities
  • Advanced analytical capabilities and proficiency with financial modeling tools
  • Excellent communication, presentation, and stakeholder management skills
  • Strong focus on Talent development and a continuous improvement mindset
  • Strategic Vision: Ability to see the big picture and connect finance

Responsibilities

  • Finance lead for Manufacturing Network & Product Strategy: Collaborate with Operations, Supply Chain, and Product Development teams to evaluate and optimize the global manufacturing footprint
  • Lead financial assessment and scenario modeling for manufacturing network transformations, new plant investments, site consolidations, and capacity expansions
  • Develop business case analyses for new product introductions and manufacturing process innovations, aligning financial objectives with organizational strategy
  • Own the Long-Range Financial Plan process for GPS
  • Lead a team of 5 Finance professionals
  • Oversee the multi-year capital planning process, aligning investment priorities with long-term manufacturing and product strategy goals
  • Support mergers, acquisitions, joint ventures, and partnerships related to manufacturing and industrial growth
  • Lead financial due diligence, valuation modeling, and strategic fit analysis for potential transactions
  • Champion best practices in financial planning, forecasting, and performance management, leveraging analytics to drive decision-making
  • Foster a culture of transparency, accountability, and continuous improvement within the finance organization

Skills

Financial Strategy
Capital Planning
Financial Modeling
Scenario Analysis
Manufacturing Network Optimization
Supply Chain Finance
Risk Management
Business Development
Asset Allocation

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI